Evidence
Neuroreport. 2023 Aug 24;34(11):546-550. doi: 10.1097/WNR.0000000000001923. Epub 2023 Jun 7.
ABSTRACT
Tau protein accumulation in the brain is thought to be one of the causes of Alzheimer’s disease (AD). Recent studies found that the choroid plexus (CP) has a role in β-amyloid and tau protein clearance in the brain. We evaluated the relationships between CP volume and the ß-amyloid and tau protein depositions. Participants were 20 patients with AD and 35 healthy subjects who underwent MRI and PET scanning using the ß-amyloid tracer 11C-PiB and the tau/inflammatory tracer 18F-THK5351. We computed the volume of the CP and estimated the relationships between the CP volume and ß-amyloid and tau protein/inflammatory deposition by Spearman’s correlation test. The CP volume was significantly positively correlated with both the standardized uptake value ratio (SUVR) of 11C-PiB and the SUVR of 18F-THK5351 in all participants. The CP volume was also significantly positively correlated with the SUVR of 18F-THK5351in patients with AD. Our data suggested that the volume of the CP was a good biomarker for the evaluation of tau deposition and neuroinflammation.
PMID:37384934 | DOI:10.1097/WNR.0000000000001923
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Relationship between the tau protein and choroid plexus volume in Alzheimer’s disease
🌐 90 Days
VR Related Evidence Matrix
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Local structural preferences in shaping tau amyloid polymorphism
- Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
- Associations between sex, body mass index and the individual microglial response in Alzheimer's disease
- Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- Alzheimer's Disease: The Past, Present, and Future of a Globally Progressive Disease
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
- Deep learning segmentation of the choroid plexus from structural magnetic resonance imaging (MRI): validation and normative ranges across the adult lifespan
- Association of Plasma Markers of Alzheimer's Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging
- Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging
- β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer's disease
- Psychotic symptoms are associated with elevated tau PET signal in the amygdala independent of Alzheimer's disease clinical severity and amyloid burden
- Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
- Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)
- Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
- Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry
- Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology
- Is Alzheimer disease a disease?
- Disentangling tau: One protein, many therapeutic approaches
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
- Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
- Partial volume correction in longitudinal tau PET studies - is it really needed?
- Ensemble-based design of tau to inhibit aggregation while preserving biological activity
- Speech patterns during memory recall relates to early tau burden across adulthood
- Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates
- Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
- Use of modern classification systems for complex diagnostics of Alzheimer's disease
- Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive change
- Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation
- Molecular cross-talk between long COVID-19 and Alzheimer's disease
- Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial
- The Relationship of Cerebrospinal Fluid Biomarkers and Cognitive Performance in Frontotemporal Dementia
- Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach
- ATN Classification and Clinical Progression of the Amyloid-Negative Group in Alzheimer's Disease Neuroimaging Initiative Participants
- Quantitative Brain Amyloid PET
- Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life
- Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease
- Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient
- Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
Evidence Blueprint
Relationship between the tau protein and choroid plexus volume in Alzheimer’s disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Relationship between the tau protein and choroid plexus volume in Alzheimer’s disease
🌐 365 Days
VR Related Evidence Matrix
- Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
- Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology
- Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease
- APOEε4 potentiates amyloid β effects on longitudinal tau pathology
- Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)
- Age-, sex-, and pathology-related variability in brain structure and cognition
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography
- Association of Neurofilament Light Chain, [18F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
- Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain
- Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology
- Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden
- Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years
- Tau and Alzheimer's disease: Past, present and future
- Polypathologic associations with grey matter atrophy in neurodegenerative disease
- Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients
- Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images
- Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease
- Passive tau-based immunotherapy for tauopathies
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid
- Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases
- Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individuals
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum
- p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
- Local structural preferences in shaping tau amyloid polymorphism
- A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
- Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
- Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability
- Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two
- Associations between sex, body mass index and the individual microglial response in Alzheimer's disease
- Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS
- Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology
- Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner
- High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer's disease
- CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
- Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings
- Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
- Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
- Evaluation of possible neuroprotective effects of virgin coconut oil on aluminum-induced neurotoxicity in an in vitro Alzheimer's disease model
- Utility of amyloid PET Imaging in a Memory Clinic
- Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology
- Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains
- Alzheimer's Disease: The Past, Present, and Future of a Globally Progressive Disease